Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana

Sikhulile Moyo^1*, Hermann Bussmann^1,2, Phibeon Mangwendeza¹, Priti Dusara¹, Tendani Gaolathe¹, Madisa Mine^1,3, Rosemary Musonda^1,2, Erik Van Widenfelt¹, Vladimir Novitsky^1,2, Joseph Makhema¹, Richard G. Marlink^1,2, Max Essex^1,2 and C. William Wester^1,2,4

¹Botswana–Harvard AIDS Institute Partnership, Gaborone, Botswana, E-mail: hermann.bussmann@med.uni-heidelberg.de

²Harvard School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA, E-mail: hermann.bussmann@med.uni-heidelberg.de

³National Health Laboratory, Gaborone, Botswana, E-mail: hermann.bussmann@med.uni-heidelberg.de

⁴Vanderbilt University School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, TN, USA, E-mail: hermann.bussmann@med.uni-heidelberg.de

^*Corresponding Author: Mr. Sikhulile Moyo, Botswana–Harvard AIDS Institute Partnership, P/Bag BO 320 Gaborone, Botswana, Fax: +267 3901284 Email: